AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10704616 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL+VLDL oxidizability
Number of subjects: 34
Study 10704616 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycemic control (HbA(1))
Number of subjects: 34
Study 10704616 — intervention group
Group type: COMPARATOR
Intervention: Type-I diabetic patients
Number of subjects: 34
Study 9347432 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane‐N2O‐opioid general anesthesia
Number of subjects: 24
Study 9347432 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined epidural‐general anesthesia
Number of subjects: 24
Study 9347432 — intervention group
Group type: COMPARATOR
Intervention: All patients (combined analysis)
Number of subjects: 24
Study 8477408 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 6
Study 2943760 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 1% clindamycin phosphate applied twice daily for 8 weeks
Number of subjects: 32
Study 2943760 — intervention group
Group type: COMPARATOR
Intervention: Vehicle applied twice daily for 8 weeks
Number of subjects: 32
Study 31480553 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine supplement (CAF; 6 mg∙kg‐1)
Number of subjects: 15
Study 31480553 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 15
Study 27198532 — intervention group
Group type: EXPERIMENTAL
Intervention: FHH-based assessments provided to all adult household members
Number of subjects: 1401
Study 27198532 — intervention group
Group type: COMPARATOR
Intervention: FHH-based assessments provided to one adult household member
Number of subjects: 1401
Study 27198532 — intervention group
Group type: EXPERIMENTAL
Intervention: New encouragement from parent-to-child
Number of subjects: 1401
Study 27198532 — intervention group
Group type: EXPERIMENTAL
Intervention: New encouragement from child-to-parent
Number of subjects: 1401
Study 27198532 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline encouragement for PA and HW
Number of subjects: 1401
Study 27198532 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline co-engagement in PA
Number of subjects: 1401
Study 25677309 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 231
Study 25677309 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 231
Study 24090039 — intervention group
Group type: EXPERIMENTAL
Intervention: Bespoke online clinical skills training videos (TV)
Number of subjects: 22
Study 24090039 — intervention group
Group type: COMPARATOR
Intervention: Revision as usual (RAU)
Number of subjects: 22
Study 24090039 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (TV and RAU)
Number of subjects: 22
Study 22379770 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum-assisted venous drainage technology (VAVD) during cardiopulmonary bypass (CPB) in MICS
Number of subjects: 70
Study 19556801 — intervention group
Group type: EXPERIMENTAL
Intervention: Injections every month for 6 months, then every 3 months for a total of 15 months
Number of subjects: 112
Study 19556801 — intervention group
Group type: COMPARATOR
Intervention: Injections every 3 months for 15 months
Number of subjects: 112
Study 17595452 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (2800 mg daily for 7 days)
Number of subjects: 52
Study 17595452 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 15493391 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 40
Study 15493391 — intervention group
Group type: COMPARATOR
Intervention: 3% mepivacaine
Number of subjects: 40
Study 11158795 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscocanalostomy
Number of subjects: 20
Study 11158795 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy
Number of subjects: 20
Study 10099043 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate 50 mg intramuscularly weekly and 1,000 mg oral calcium carbonate daily (NDC group)
Number of subjects: 21
Study 10099043 — intervention group
Group type: COMPARATOR
Intervention: Calcium alone 1,000 mg oral calcium carbonate daily (CAL group)
Number of subjects: 21
Study 7656846 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary bisoprolol (0.01 mg/kg body weight)
Number of subjects: 14
Study 7656846 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous bisoprolol (2.5 mg)
Number of subjects: 14
Study 2741219 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-epiadriamycin and cyclophosphamide for 8 courses followed by 6 cycles of CMF and MPA until progression (Group A)
Number of subjects: 250
Study 2741219 — intervention group
Group type: EXPERIMENTAL
Intervention: Adriamycin + cyclophosphamide alternated with CMF every two courses until 14 cycles completed (Group B)
Number of subjects: 250
Study 2741219 — intervention group
Group type: EXPERIMENTAL
Intervention: 4'-epiadriamycin + cyclophosphamide alternated with CMF for 14 courses (Group C)
Number of subjects: 250
Study 237849 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromazepam (5 mg t.d.s. for 3 weeks)
Number of subjects: 30
Study 237849 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (5 mg t.d.s. for 3 weeks)
Number of subjects: 30
Study 237849 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromazepam
Number of subjects: 30
Study 237849 — intervention group
Group type: COMPARATOR
Intervention: Bromazepam and Diazepam
Number of subjects: 30
Study 31886931 — intervention group
Group type: EXPERIMENTAL
Intervention: Met + Lifestyle
Number of subjects: 450
Study 31886931 — intervention group
Group type: COMPARATOR
Intervention: Metformin (Met)
Number of subjects: 450
Study 31886931 — intervention group
Group type: COMPARATOR
Intervention: Met + Rosiglitazone (Rosi)
Number of subjects: 450
Study 30935251 — intervention group
Group type: EXPERIMENTAL
Intervention: SCFW (water-based facial sunscreen)
Number of subjects: 0
Study 28291977 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance-dependent women (alcohol and opiate)
Number of subjects: 62
Study 28291977 — intervention group
Group type: EXPERIMENTAL
Intervention: Opiate-dependent females
Number of subjects: 62
Study 28291977 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-dependent females
Number of subjects: 62
Study 28291977 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 62
Study 26678937 — intervention group
Group type: EXPERIMENTAL
Intervention: IV paracetamol
Number of subjects: 104
Study 26678937 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 25402241 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified glass ionomer resin sealant (Vitremer, 3M ESPE) with oral health education every three months + a single application of sealant
Number of subjects: 268
Study 25402241 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish (Duraphat, Colgate) with oral health education every three months + varnish biannually
Number of subjects: 268
Study 25402241 — intervention group
Group type: COMPARATOR
Intervention: High risk controls (oral health education every three months)
Number of subjects: 268
Study 25402241 — intervention group
Group type: COMPARATOR
Intervention: Low risk controls (oral health education every three months)
Number of subjects: 268
Study 25402241 — intervention group
Group type: EXPERIMENTAL
Intervention: High risk with varnish (oral health education every three months + varnish biannually)
Number of subjects: 268
Study 25402241 — intervention group
Group type: EXPERIMENTAL
Intervention: Low risk with varnish (oral health education every three months + varnish biannually)
Number of subjects: 268
Study 25402241 — intervention group
Group type: EXPERIMENTAL
Intervention: High risk with sealant (oral health education every three months + a single application of sealant)
Number of subjects: 268
Study 25402241 — intervention group
Group type: EXPERIMENTAL
Intervention: Low risk with sealant (oral health education every three months + a single application of sealant)
Number of subjects: 268
Study 21840466 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet (40% of energy as fat)
Number of subjects: 16
Study 21840466 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (20% of energy)
Number of subjects: 16
Study 21840466 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet + n-3 fatty acids (20% of energy plus 3% as n-3 fatty acids)
Number of subjects: 16
Study 21840466 — intervention group
Group type: EXPERIMENTAL
Intervention: Thr54 allele carriers
Number of subjects: 16
Study 21840466 — intervention group
Group type: EXPERIMENTAL
Intervention: Ala54 allele carriers
Number of subjects: 16
Study 19274788 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice-ORS
Number of subjects: 175
Study 19274788 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fluid
Number of subjects: 175
Study 19274788 — intervention group
Group type: COMPARATOR
Intervention: All ORSs
Number of subjects: 175
Study 17206426 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose multidetector computed tomography (MDCT) screening for lung cancer
Number of subjects: 1929
Study 15266172 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc depreotide scan
Number of subjects: 12
Study 15266172 — intervention group
Group type: COMPARATOR
Intervention: 99mTc-MDP bone scintigraphy
Number of subjects: 12
Study 11339397 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper pole placement (Group A)
Number of subjects: 40
Study 11339397 — intervention group
Group type: COMPARATOR
Intervention: Renal pelvis placement (Group B)
Number of subjects: 40
Study 9155961 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 150 mg once weekly for 4-6 weeks
Number of subjects: 230
Study 9155961 — intervention group
Group type: COMPARATOR
Intervention: Griseofulvin 500 mg once daily for 4-6 weeks
Number of subjects: 230
Study 7952982 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 64
Study 7952982 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied relaxation
Number of subjects: 64
Study 7952982 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (mean 233 mg/day)
Number of subjects: 64
Study 7952982 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 64
Study 7952982 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 64
Study 3417989 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon monoxide exposure (mean postexposure carboxyhemoglobin 5.9 +/- 0.1%)
Number of subjects: 30
Study 3417989 — intervention group
Group type: COMPARATOR
Intervention: Air exposure (mean postexposure carboxyhemoglobin 1.6 +/- 0.1%)
Number of subjects: 30
Study 3417989 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon monoxide exposure
Number of subjects: 30
Study 3417989 — intervention group
Group type: COMPARATOR
Intervention: Air exposure
Number of subjects: 30
Study 3417989 — intervention group
Group type: EXPERIMENTAL
Intervention: Both exposures
Number of subjects: 30
Study 31101138 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory N-back task (NBT)
Number of subjects: 39
Study 31101138 — intervention group
Group type: COMPARATOR
Intervention: Control group (no NBT)
Number of subjects: 39
Study 29198188 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 g milk
Number of subjects: 14
Study 29198188 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 g yogurt
Number of subjects: 14
Study 26317357 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (Group D) with rocuronium infusion, maintaining a post-tetanic count of 1-2.
Number of subjects: 67
Study 26317357 — intervention group
Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade (Group M) with atracurium infusion, maintaining a train of four count of 1-2.
Number of subjects: 67
Study 26317357 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall surgical condition grade in Group D.
Number of subjects: 67
Study 26317357 — intervention group
Group type: COMPARATOR
Intervention: Overall surgical condition grade in Group M.
Number of subjects: 67
Study 23683794 — intervention group
Group type: EXPERIMENTAL
Intervention: Illicit use of prescription stimulants (IUPS)
Number of subjects: 520
Study 21318438 — intervention group
Group type: EXPERIMENTAL
Intervention: Social integration (measured by AVSI) in former ICU patients
Number of subjects: 0
Study 21318438 — intervention group
Group type: COMPARATOR
Intervention: General reference group (n = 6,093)
Number of subjects: 0
Study 18446582 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-infrared spectroscopy (NIRS) during reading aloud
Number of subjects: 0
Study 18446582 — intervention group
Group type: COMPARATOR
Intervention: Control condition (5 min of resting with eyes closed)
Number of subjects: 0
Study 17381575 — intervention group
Group type: EXPERIMENTAL
Intervention: Single use intubating laryngeal mask airway (Group S)
Number of subjects: 84
Study 17381575 — intervention group
Group type: COMPARATOR
Intervention: Reusable intubating laryngeal mask airway (Group C)
Number of subjects: 84
Study 17381575 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Group S and Group C)
Number of subjects: 84
Study 14764813 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment
Number of subjects: 50
Study 14764813 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum from GH-treated healthy subjects
Number of subjects: 50
Study 14764813 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 11157651 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulants (INR 2.0 to 3.0)
Number of subjects: 0
Study 11157651 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulants (INR 2.5 to 3.5)
Number of subjects: 0
Study 11157651 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin in addition to oral anticoagulants
Number of subjects: 0
Study 11157651 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulants (INR 2.0 to 2.3)
Number of subjects: 0
Study 11157651 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0
Study 11157651 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole plus aspirin
Number of subjects: 0
Study 11157651 — intervention group
Group type: EXPERIMENTAL
Intervention: Low doses of aspirin
Number of subjects: 0
Study 11157651 — intervention group
Group type: EXPERIMENTAL
Intervention: Caged ball or caged disk valves (INR 3.0-4.5)
Number of subjects: 0
Study 9137023 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal penile nerve block (DPNB)
Number of subjects: 30
Study 9137023 — intervention group
Group type: COMPARATOR
Intervention: Unanesthetized
Number of subjects: 30
Study 7956473 — intervention group
Group type: EXPERIMENTAL
Intervention: Normative context
Number of subjects: 0
Study 7956473 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptual context
Number of subjects: 0
Study 7956473 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional context
Number of subjects: 0
Study 3612778 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior modification
Number of subjects: 0
Study 3612778 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive modification
Number of subjects: 0
Study 3612778 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavior modification
Number of subjects: 0
Study 3612778 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 31856335 — intervention group
Group type: EXPERIMENTAL
Intervention: ToyBox intervention (adapted for Scotland), delivered over 18 weeks, targeting energy balance-related behaviours through teacher-led activities and parental education materials.
Number of subjects: 0
Study 30295319 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Focused Intervention
Number of subjects: 93
Study 30295319 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 93
Study 28603114 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.5mg of oral dexamethasone once a day for 3 days (study group)
Number of subjects: 162
Study 28603114 — intervention group
Group type: COMPARATOR
Intervention: 8mg of dexamethasone twice a day for 3 days (control group)
Number of subjects: 162
Study 26100690 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural catheter placement
Number of subjects: 330
Study 26100690 — intervention group
Group type: COMPARATOR
Intervention: Patient controlled analgesia (PCA)
Number of subjects: 330
Study 26100690 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Study (IS) group
Number of subjects: 330
Study 26100690 — intervention group
Group type: COMPARATOR
Intervention: Observational Study (OS) group
Number of subjects: 330
Study 24316430 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycosylated 1,25(OH)2D3, single oral dose, up to 40-fold the recommended daily dose (0.5μg/subject/day)
Number of subjects: 16
Study 24316430 — intervention group
Group type: COMPARATOR
Intervention: Synthetic 1,25(OH)2D3 (historically established pharmacokinetics)
Number of subjects: 16
Study 21878166 — intervention group
Group type: COMPARATOR
Intervention: Shock group
Number of subjects: 24
Study 21878166 — intervention group
Group type: EXPERIMENTAL
Intervention: Drainage group
Number of subjects: 24
Study 21878166 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion group
Number of subjects: 24
Study 19398065 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiljehyangbuhwan
Number of subjects: 100
Study 19398065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 17719323 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct stenting
Number of subjects: 217
Study 17719323 — intervention group
Group type: COMPARATOR
Intervention: Stenting after balloon predilation
Number of subjects: 217
Study 15071151 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoridated elastomers
Number of subjects: 30
Study 15071151 — intervention group
Group type: COMPARATOR
Intervention: Non-fluoridated elastomers
Number of subjects: 30
Study 11414344 — intervention group
Group type: EXPERIMENTAL
Intervention: DWI school plus MADD VIP
Number of subjects: 813
Study 11414344 — intervention group
Group type: COMPARATOR
Intervention: DWI school
Number of subjects: 813
Study 10453590 — intervention group
Group type: EXPERIMENTAL
Intervention: Tang Shen Ning (TSN) + western medicine
Number of subjects: 0
Study 10453590 — intervention group
Group type: COMPARATOR
Intervention: Western medicine
Number of subjects: 0
Study 10453590 — intervention group
Group type: EXPERIMENTAL
Intervention: Tang Shen Ning (TSN)
Number of subjects: 0
Study 7881702 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium-heparin (12,500 IU once daily)
Number of subjects: 60
Study 7881702 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) (300 mg twice daily)
Number of subjects: 60
Study 7881702 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium-heparin
Number of subjects: 60
Study 7881702 — intervention group
Group type: COMPARATOR
Intervention: ASA
Number of subjects: 60
Study 3108922 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5‐5 mg haloperidol orally and/or intravenously
Number of subjects: 9
Study 31926142 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality-Based Therapy (VRBT)
Number of subjects: 27
Study 31926142 — intervention group
Group type: COMPARATOR
Intervention: Cardiac Rehabilitation (CR)
Number of subjects: 27
Study 30656509 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC) 0.2 mg/mL for 2 min before surgery
Number of subjects: 38
Study 30656509 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab-methylcellulose mixture (BMM) 1.25 mg in 2% methylcellulose injected subconjunctivally after surgery
Number of subjects: 38
Study 30656509 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MMC and BMM
Number of subjects: 38
Study 27492421 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive chat condition
Number of subjects: 301
Study 27492421 — intervention group
Group type: COMPARATOR
Intervention: Negative chat condition
Number of subjects: 301
Study 27492421 — intervention group
Group type: COMPARATOR
Intervention: Natural chat condition
Number of subjects: 301
Study 25376972 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor Canal Block (ACB) with ropivacaine 0.2% 30 mL
Number of subjects: 50
Study 25376972 — intervention group
Group type: COMPARATOR
Intervention: Femoral Nerve Block (FNB) with ropivacaine 0.2% 30 mL
Number of subjects: 50
Study 25376972 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 23657413 — intervention group
Group type: EXPERIMENTAL
Intervention: Corega Brite combined with Oral Balance (artificial saliva)
Number of subjects: 23
Study 23657413 — intervention group
Group type: EXPERIMENTAL
Intervention: Corega Brite denture dentifrice
Number of subjects: 23
Study 23657413 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral liquid soap
Number of subjects: 23
Study 23657413 — intervention group
Group type: COMPARATOR
Intervention: Tap water
Number of subjects: 23
Study 21673483 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher protein (HP) diet
Number of subjects: 221
Study 21673483 — intervention group
Group type: COMPARATOR
Intervention: Higher carbohydrate (HC) diet
Number of subjects: 221
Study 21673483 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise + HP diet in HH group
Number of subjects: 221
Study 21673483 — intervention group
Group type: COMPARATOR
Intervention: Exercise + HC diet in HH group
Number of subjects: 221
Study 19892673 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CYC)
Number of subjects: 98
Study 19892673 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 17106661 — intervention group
Group type: EXPERIMENTAL
Intervention: Spa therapy (daily local mud packs and arsenical ferruginous mineral bath water) for 3 weeks
Number of subjects: 74
Study 17106661 — intervention group
Group type: EXPERIMENTAL
Intervention: Short wave therapy for 3 weeks
Number of subjects: 74
Study 17106661 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (routine ambulatory care)
Number of subjects: 74
Study 14633141 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1 g twice daily 24 hours before and after angiography
Number of subjects: 53
Study 14633141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 14633141 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 53
Study 10860688 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter coated with hydrogel and silver salts (group 2)
Number of subjects: 199